Combined therapy of L1210 leukemia with Damvar and cytostatics.
作者信息
Pujman V, Cernochová S
出版信息
Neoplasma. 1979;26(5):521-3.
PMID:522924
Abstract
Damvar, the delta-(2-amino-6-hydroxy-3,4-dihydro-4-oxo-5-pyrimidinyl) valeric acid, administered alone s. c. or i. p., has no effect on L1210 leukemia. In DBA2 mice with L1210, Damvar administered in combination with 5-fluorouracil, or with 6-mercaptopurine, or with cyclophosphamide, in optimal doses, enhances or intensifies the antileukemic effects of the above cytostatics.
摘要
相似文献
1
Combined therapy of L1210 leukemia with Damvar and cytostatics.
Neoplasma. 1979;26(5):521-3.
2
Combined therapy of leukemia La with Damvar and cytostatics.
Neoplasma. 1979;26(1):85-8.
3
Single versus combination chemotherapy of L1210 leukemia.L1210白血病的单药化疗与联合化疗
Neoplasma. 1980;27(6):691-6.
4
Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
Cancer Chemother Rep 2. 1971 Apr;2(1):65-133.
5
6
7
Rationale of chemotherapeutic adjuvant treatment.化疗辅助治疗的基本原理。
Arch Geschwulstforsch. 1978;48(7):627-35.
8
Pharmacokinetics of Damvar.
Neoplasma. 1982;29(2):223-32.
9
Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.小鼠L1210白血病观察到的耐药性基础：以不同组合给予甲氨蝶呤、6-硫鸟嘌呤、6-甲基巯基嘌呤核苷、6-巯基嘌呤、5-氟尿嘧啶和1-β-D-阿拉伯呋喃糖基胞嘧啶。
Cancer Res. 1981 Nov;41(11 Pt 1):4529-34.
10
Effect of azathioprine on antibody formation in mice and its modification by delta-(2-amino-6-hydroxy-3,4-dihydro-4-oxo-5-pyrimidinyl)-valeric acid.
Arzneimittelforschung. 1980;30(6):978-80.
Zotero 插件